Ashley Brooks
Impact in
-
- Diabetes Treatment and Management
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Surgery top 10%
- Lipoproteins and Cardiovascular Health
Papers in
-
- Metabolism, Diabetes, and Cancer 2
- ATP Synthase and ATPases Research 1
- Glycosylation and Glycoproteins Research 1
-
- Diabetes Treatment and Management 3
- Co-authors
- David Kallend (1 shared paper)Jay D. Horton (1 shared paper)Amy Simon (1 shared paper)Robert S. Kauffman (1 shared paper)Kevin Fitzgerald (1 shared paper)Jörg Täubel (1 shared paper)Anna Borodovsky (1 shared paper)Valerie A. Clausen (1 shared paper)
- Journals
- Diabetes Obesity and Metabolism (2 papers)British Journal of Clinical Pharmacology (1 paper)Journal of Forensic Sciences (1 paper)Canadian Journal of Diabetes (1 paper)Scientific Reports (1 paper)
- Partner nations
- United KingdomUnited StatesDenmark
In The Last Decade
Ashley Brooks
12 papers receiving 949 citations
Ashley Brooks's Hit Papers
Peers
Comparison fields: 5 of 70
- Endocrinology, Diabetes and Metabolism 239
- Surgery 342
- Cancer Research 105
- Molecular Biology 339
- Cardiology and Cardiovascular Medicine 96
Countries citing papers authored by Ashley Brooks
This map shows the geographic impact of Ashley Brooks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashley Brooks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashley Brooks more than expected).
Fields of papers citing papers by Ashley Brooks
This network shows the impact of papers produced by Ashley Brooks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashley Brooks. The network helps show where Ashley Brooks may publish in the future.
Co-authors
The 25 scholars most cited alongside Ashley Brooks, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A Highly Durable RNAi Therapeutic Inhibitor of PCSK9 Hit paper breakdown → | 2016 | 610 |
| 2 | 2017 | 174 | |
| 3 | 2021 | 62 | |
| 4 | 2023 | 28 | |
| 5 | 2018 | 27 | |
| 6 | 2014 | 19 | |
| 7 | 2023 | 18 | |
| 8 | 2016 | 10 | |
| 9 | 2025 | 5 | |
| 10 | 2016 | 4 | |
| 11 | 2023 | 3 | |
| 12 | 2023 | 3 |
About Ashley Brooks
Ashley Brooks is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism, Surgery, Pharmacology and Immunology, having authored 12 papers that have together received 963 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (3 papers), Metabolism, Diabetes, and Cancer (2 papers), ATP Synthase and ATPases Research (1 paper), Cardiac electrophysiology and arrhythmias (1 paper), Glycosylation and Glycoproteins Research (1 paper), Human-Animal Interaction Studies (1 paper), Galectins and Cancer Biology (1 paper) and Metabolism and Genetic Disorders (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (239 citations), Surgery (342 citations), Cancer Research (105 citations), Molecular Biology (339 citations) and Cardiology and Cardiovascular Medicine (96 citations). Ashley Brooks has collaborated with scholars based in United Kingdom, United States and Denmark. Frequent co-authors include David Kallend, Jay D. Horton, Amy Simon, Robert S. Kauffman, Kevin Fitzgerald, Jörg Täubel, Anna Borodovsky, Valerie A. Clausen, Akshay Vaishnaw and Brian R. Bettencourt. Their work appears in journals such as Diabetes Obesity and Metabolism, British Journal of Clinical Pharmacology, Journal of Forensic Sciences, Canadian Journal of Diabetes and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.